Buscar
Mostrando ítems 1-10 de 161
Detection of hepatitis C virus resistant mutants in the era of direct acting antivirals
(2014-01-01)
Hepatitis C Virus (HCV) infects millions of people and represents an important public health problem in different regions of the world. Drug resistance is a major challenge for HCV-infection related control. Importantly, ...
Detection of hepatitis C virus resistant mutants in the era of direct acting antivirals
(2014-01-07)
Hepatitis C Virus (HCV) infects millions of people and represents an important public health problem in different regions of the world. Drug resistance is a major challenge for HCV-infection related control. Importantly, ...
Hepatitis C virus resistance to the new direct-acting antivirals
(Informa Healthcare, 2016-07)
Introduction: The treatment of hepatitis C virus (HCV) infection has dramatically improved in recent years with the widespread use of interferon-free combination regimens. Despite the high sustained virological response ...
Plant-derived antivirals against hepatitis c virus infection
(Biomed Central Ltd, 2018-02-13)
Hepatitis C virus (HCV) infection is a worldwide public health burden and it is estimated that 185 million people are or have previously been infected worldwide. There is no effective vaccine for prevention of HCV infection; ...
Direct-acting antiviral agents for HCV-associated glomerular disease and the current evidence
(Molecular Diversity Preservation International, 2019-10)
Glomerular disease is an extra-hepatic manifestation of hepatitis C virus infection (HCV) and membranoproliferative glomerulonephritis is the most frequent glomerular disease associated with HCV. It occurs commonly in ...
History and progress of antiviral drugs: from acyclovir to direct-acting antiviral agents (DAAs) for Hepatitis C
(UANL. Facultad de Medicina, 2015)
Prevalence and factors related to natural resistance-associated substitutions to direct-acting antivirals in patients with genotype 1 hepatitis C virus infection
(MDPI AG, 2019-01-21)
This study aimed to assess the prevalence of natural resistance-associated substitutions (RASs) to NS3, NS5A and NS5B inhibitors in 86 genotype 1 Hepatitis C Virus (HCV)-infected patients from Buenos Aires, Argentina, and ...
Hepatitis C virus molecular evolution: Transmission, disease progression and antiviral therapy
(Baishideng Publishing Group, 2014-11)
Hepatitis C virus (HCV) infection represents an important public health problem worldwide. Reduction of HCV morbidity and mortality is a current challenge owned to several viral and host factors. Virus molecular evolution ...